Evidence map›Paper›PMID 42910546›Full record

ArticleMolecular genetics & genomic medicine2026

Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb-Girdle Muscular Dystrophy.

Parnian Alagha, Fatemeh Ahangari, Ariana Kariminejad, Aida Ghasemi, Soheila Gholami, Neda Sadatian, Roxana Kariminejad, Kimia Kahrizi, Ali Asghar Okhovat, Hossein Najmabadi

Abstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Parnian AlaghaKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.ORCID https://orcid.org/0009-0005-0574-6535
Fatemeh AhangariKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.
Ariana KariminejadKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.ORCID https://orcid.org/0000-0002-8467-4728
Aida GhasemiNeuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-6386-7961
Soheila GholamiKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.
Neda SadatianKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.
Roxana KariminejadKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.ORCID https://orcid.org/0000-0003-1943-2391
Kimia KahriziKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.ORCID https://orcid.org/0000-0002-6587-7706
Ali Asghar OkhovatNeuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-9286-4943
Hossein NajmabadiKariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.ORCID https://orcid.org/0000-0002-6084-7778

Funding

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences and Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran 1404/801/A/6/10220
6 · The paper itself

Abstract

backgroundDystroglycanopathies are a clinically and genetically heterogeneous group of muscular dystrophies caused by impaired glycosylation of α-dystroglycan, with variants in multiple genes, including CRPPA, which is associated with a broad spectrum ranging from congenital muscular dystrophy to limb-girdle muscular dystrophy.

methodThe proband underwent whole exome sequencing, while Sanger sequencing was used for segregation analysis and oligonucleotide array-CGH was performed to confirm the copy number variant.

resultsWe report two siblings harboring an identical novel compound heterozygous CRPPA genotype, comprising a novel c.267G>C missense variant and a deletion encompassing exons 9-10. Despite sharing the same genotype, the siblings showed marked phenotypic variability. The female sibling developed childhood-onset disease with proximal weakness involving both the upper and lower limbs, whereas the male sibling presented with late-onset disease and weakness confined to the proximal lower limbs, accompanied by markedly discordant serum creatine kinase levels (1193 vs. 460 U/L).

conclusionThese findings expand the mutational and clinical spectrum of CRPPA-related dystroglycanopathy, highlight marked intrafamilial phenotypic variability, and emphasize the importance of integrated single-nucleotide and copy number variant analysis in the genetic diagnosis of neuromuscular disorders.

Indexed as

Muscular Dystrophies, Limb-GirdleNucleotidyltransferasesPhenotypeAdultDNA Copy Number VariationsFemaleHeterozygoteHumansIranMaleMutation, MissensePedigreeSiblingsCRPPA protein, humanNucleotidyltransferasesarray‐CGHcopy number variant (CNV)CRPPAdystroglycanopathieslimb‐girdle muscular dystrophy (LGMD)whole exome sequencing (WES)

Identifiers

PMID42910546
PMCPMC13688433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.